NAT10/ac 4 C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling
Proceedings of the National Academy of Sciences · 19.05.2026 · 123 (20)
DOI: 10.1073/pnas.2532263123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 14.05.2026. Verfasst von Yunkun Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Chromatin Assembly and Disassembly, Bile Duct Neoplasms, DNA Transposable Elements. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | NSFC | NSFC-Zhejiang Joint Fund | | Natural Science Foundation of Zhejiang Province (ZJNSF), MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs).
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (ICC) poses a significant clinical challenge due to its insidious onset, aggressive biological behavior, and propensity for early metastasis, contributing to a dismal 5-y survival rate of less than 10%. Despite advances in understanding the dynamic changes in gene regulatory networks and chromatin landscapes during tumorigenesis, the functional interplay between RNA epitranscriptomic modifications and nuclear events in ICC remains poorly elucidated. Here, we identify N -acetyltransferase 10 (NAT10), the writer for N 4 -acetylcytidine (ac 4 C) mRNA modification, as a critical regulator of ICC malignancy. Integrated multiomics profiling reveals that NAT10-mediated ac 4 C modification enhances the mRNA stability of chromatin assembly factor 1 subunit A (CHAF1A), a key chromatin regulator. Mechanistically, the NAT10–ac 4 C–CHAF1A axis robustly and epigenetically suppresses the expression of the nuclear transposable element HERV9NC, leading to diminished double-stranded RNA accumulation. This epigenetic silencing not only fuels ICC proliferation and migration but also attenuates intrinsic innate immune responses, thereby fostering an immunosuppressive tumor microenvironment characterized by reduced cytotoxic T cell infiltration and impaired tumor surveillance. Pharmacological inhibition of NAT10 with small-molecule compounds demonstrated robust therapeutic efficacy in both patient-derived xenograft and orthotopic tumor transplantation models of ICC. Collectively, our study unveils NAT10 as a master integrator of RNA epitranscriptomic reprogramming and nuclear chromatin dynamics in ICC, providing interesting mechanistic insights into the molecular basis of ICC progression. We also establish NAT10-ac 4 C modification as a druggable vulnerability, offering a promising therapeutic strategy for this aggressive malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
- National Engineering Research Center of Innovation and Application of Minimally Invasive Instruments, Hangzhou 310016, China.
- Provincial Key Laboratory of Minimally Invasive Procedure and Precision Medicine, Hangzhou 310016, China.
- Zhejiang University Cancer Center, Hangzhou 310058, China.
- College of Life Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
- Department of Gastroenterology, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
ORCID-Profile: Yunkun Lu, Kainan Lin, Peng Xiao, Hongjun Chen, Shunmin He, Junjie Xu
Förderung
- MOST | NSFC | NSFC-Zhejiang Joint Fund | | Natural Science Foundation of Zhejiang Province (ZJNSF)
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | National Key Research and Development Program of China (NKPs)
- Zhejiang Provincial Natural Science Foundation of China
- MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province
Zitieren
APA
Lu, Y., Lin, K., Wang, Q., Huang, X., Lin, L., Dou, J., Jiao, Y., Wang, Y., Xiao, P., Chen, H., Li, S., Xue, Y., He, S., & Xu, J. (2026). NAT10/ac 4 C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling. Proceedings of the National Academy of Sciences, 123(20). https://doi.org/10.1073/pnas.2532263123
Vancouver
Lu Y, Lin K, Wang Q, Huang X, Lin L, Dou J, et al. NAT10/ac 4 C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling. Proceedings of the National Academy of Sciences. 2026;123(20). doi:10.1073/pnas.2532263123
BibTeX
@article{Lu2026,
author = {Lu, Yunkun and Lin, Kainan and Wang, Qianqian and Huang, Xiang and Lin, Lianyu and Dou, Jie and Jiao, Yajuan and Wang, Yali and Xiao, Peng and Chen, Hongjun and Li, Silin and Xue, Yangtao and He, Shunmin and Xu, Junjie},
title = {NAT10/ac 4 C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {20},
doi = {10.1073/pnas.2532263123}
}
EUVIMED